Click here to register for all our upcoming webinars.
Clinical Trials in Australia
In partnership with Austrade and IQVIA, this webinar explores how to conduct clinical trials in Australia, including the benefits, process, due diligence issues and how to apply for an R&D tax incentive.
Conducting Clinical Trials in Australia for Chinese and Korean Companies
Access the sessions: China webinar (in Mandarin) | Korea webinar (English)
Please contact Brittany Death for a copy of the recoding.
Explores the benefits of conducting clinical trials in Australia, the steps in the clinical trial process, due diligence issues to consider and how to apply for an Australian R&D tax incentive.
Compliance Issues Arising out of Global Clinical Trials
The session explores a case study on compliance issues arising out of global clinical trials such as local regulatory and compliance issues, FDA regulatory issues, FCPA and anti-bribery issues, and M&A red flags.
16th Annual Healthcare Industry Legal and Compliance Forum
Please contact Cristina Barrobes and Rosie Slade for a copy of the recording.
A look at the key compliance issues companies need to consider before (due diligence), during (representation and warranties) and after (cleanup) any M&A transaction.
Asia Pacific Digital Transformation in Healthcare & Life Sciences
Our regional experts cover the legal and regulatory implications across the full product life cycle such as R&D, collaboration and licensing, telemedicine, product launch and promotions, as well as product liability and risk management in case of an adverse event.
EU Medical Devices
Introduction to EU Medical Devices Regulations
This webinar analyzes the drivers behind the main changes of the new EU regulations for medical devices (MDR) and in vitro diagnostic medical devices (IVDR) as well as covers the impact of Brexit.
New EU Data Protection Regulation and Impact on Medical Devices
The session takes a look at the General Data Protection Regulation (GDPR), the impact of Brexit on the implementation and a four-step approach "fit for GDPR."
Hot in Healthcare Series
Melding Health and Tech with M&A: Are You Buying the Right Tools with the Right Partners?
Explores how healthcare companies, technology companies and financial investors can succeed in M&A within the digital health space.
What IS Hot in Healthcare?
This session analyzes current and projected trends for digital health, including the challenges in introducing new technologies to the UK market and how to overcome them.
What IS Hot, Politically?
A look at the current political climate in terms of COVID-19 and Brexit, while exploring the UK's life sciences industry, trade negotiation position and other issues arising from the pandemic.
How Hot Is Your Data?
Looks into the legal hurdles and ethics of patient data by exploring how to build patient trust in digital health and by understanding the value of healthcare data and commercial models for data sharing.
Lessons from COVID-19: Compulsory Licensing in a New World
Contact Grace Gato for a copy of the recording.
A region-by-region look at the evolving compulsory licensing regimes and how they are being shaped by the pandemic.
Spotlight on Trade Secrets in Healthcare
Did you know that one-third of healthcare companies have suffered from trade secrets theft? What are firms doing to protect their trade secrets? This webinar provides insights on how to reduce the risk of trade secrets theft.
The Fake Drug Industry: A Strategic View of Global Enforcement
The session focuses on anti-counterfeiting in the pharmaceutical industry, covering comparative enforcement regimes and recent legal developments.
A Buyer's Guide to M&A in Latin America: A Focus on Healthcare
The webinar provides insights on the healthcare M&A outlook in the region, getting deals done in the current economic context and regulatory, compliance and due diligence tips.
Preparing for International Tax Reform (BEPS 2.0) from the Perspective of Healthcare Companies (hosted by Lexology)
Please contact Cristina Barrobes and Jettie Groot for a copy of the recording.
Focuses on the potential tax implications for pharmaceutical and medical technology companies of the OECD's blueprints for Pillar One and Pillar Two of the BEPS project. The second half of the webinar features a panel with tax directors from the industry on their thoughts on how they see BEPS 2.0 changing the role of tax in shaping the business models of the future and how tax departments can prepare for what is looming on the not-so-distant horizon.